Key result
New-onset atrial fibrillation following TAVI was associated with an increased risk of death (RR 1.61; 95% CI 1.35-1.98) and cerebrovascular events (RR 1.79; 95% CI 1.24-2.64).
Why the study?
What is the prevalence of new-onset arrhythmias following TAVI and do they increase the risk of death or cerebrovascular events?
Meta-Analysis (n=43,506)
What is the prevalence of new-onset arrhythmias following TAVI and do they increase the risk of death or cerebrovascular events?
Relative Risk: 1.61 (95% CI 1.35–1.98)
New-onset atrial fibrillation is a frequent complication after TAVI and is associated with significantly increased risks of mortality and cerebrovascular events.
No takes yet. Share an insight, caveat, or question.
New-onset arrhythmias post-TAVI may raise death/CVE risk; leaves open optimal detection strategies and management.
Siontis et al. (2017) conducted a meta-analysis in Transcatheter aortic valve implantation (TAVI) (n=43,506). New-onset atrial fibrillation (NOAF) vs. No NOAF was evaluated on Risk of death (RR 1.61, 95% CI 1.35 to 1.98). New-onset atrial fibrillation following TAVI was associated with an increased risk of death (RR 1.61; 95% CI 1.35-1.98) and cerebrovascular events (RR 1.79; 95% CI 1.24-2.64).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: